Rosalie Scholtes - Dissemin

Language
Login

All papers authored by Rosalie Scholtes

This paper was not found in any repository, but could be made available legally by the author.

2022 Rosalie A. Scholtes

ORCID

, Charlotte M. Mosterd, Anne C. Hesp, Mark M. Smits, Hiddo J. L. Heerspink

ORCID

, Daniël H. van Raalte

Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Taha Sen

ORCID

, Rosalie Scholtes

ORCID

, Peter J. Greasley

ORCID

, David Z. I. Cherney

ORCID

, Claire C. J. Dekkers

ORCID

, Marc Vervloet

ORCID

, Alexander H. J. Danser

ORCID

, Sean J. Barbour, Cecilia Karlsson, Ann Hammarstedt, Qiang Li, Gozewijn D. Laverman

ORCID

, Petter Bjornstad

ORCID

, Daniel H. van Raalte, Hiddo J. L. Heerspink

ORCID

Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND

Upload

This paper was not found in any repository, but could be made available legally by the author.

Rosalie A. Scholtes

ORCID

, Marcel H. A. Muskiet, Michiel J. B. van Baar, Anne C. Hesp, Peter J. Greasley, Ann Hammarstedt, Cecilia Karlsson, Karen M. Hallow, A. H. Jan Danser, Hiddo J. L. Heerspink

ORCID

, Daniël H. van Raalte

The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet

Upload

This paper was not found in any repository, but could be made available legally by the author.

2020 Rosalie A. Scholtes

ORCID

, Isabel T. N. Nguyen, Erik J. M. van Bommel

ORCID

, Nel Willekes, Melanie van Nieuwenhuijzen, Daniël H. van Raalte, Jaap A. Joles

ORCID

Glucosuria Interferes With Measurement of Effective Renal Plasma Flow Using para-Aminohippuric Acid, With a Focus on SGLT2 Inhibitors

Upload

This paper is made freely available by the publisher.

2019 Rosalie A. Scholtes

ORCID

, Daniël H. van Raalte

ORCID

, Daniël H. Raalte, Ricardo Correa‐Rotter, Robert D. Toto, Hiddo J. L. Heerspink

ORCID

, Valerie Cain, C. David Sjöström, Peter Sartipy, Bergur V. Stefánsson

The effects of dapagliflozin on cardio‐renal risk factors in patients with type 2 diabetes with or without renin‐angiotensin system inhibitor treatment: a post hoc analysis

Download from onlinelibrary.wiley.com

This paper is made freely available by the publisher.

Rosalie A. Scholtes

ORCID

, Michaël J. B. van Baar

ORCID

, Michaël J. B. Baar, Daniël H. van Raalte

ORCID

, Yuliya Lytvyn

ORCID

, Petter Bjornstad

ORCID

, Max Nieuwdorp, David Z. I. Cherney, Daniël H. Raalte

Sodium glucose cotransporter (SGLT)‐2 inhibitors: Do we need them for glucose‐lowering, for cardiorenal protection or both?

Download from api.wiley.com

Missing publications? Search for publications with a matching author name.